Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1991-08-23
1993-09-07
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
548548, A61K 4902, C07D207448
Patent
active
052426807
ABSTRACT:
Novel thiol-reactive maleimido-based radiolabeling reagents are disclosed which are useful for binding and receptor studies and assays. The reagents are also useful as diagnostic imaging agents, and as radiotherapeutic drugs.
REFERENCES:
patent: 3265708 (1966-08-01), Stiteler
patent: 3337584 (1967-08-01), Knock
patent: 4542225 (1985-09-01), Blatter et al.
patent: 4735792 (1988-04-01), Srivastava
patent: 4885153 (1989-12-01), Wilbur et al.
patent: 4994557 (1991-02-01), Kassis et al.
patent: 5045303 (1991-09-01), Wilbur et al.
Covert John M.
Daniel Mark R.
DiPrima Joseph F.
Merck & Co. , Inc.
Stoll Robert L.
LandOfFree
Thiol-reactive maleimido-based radiolabeling reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiol-reactive maleimido-based radiolabeling reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiol-reactive maleimido-based radiolabeling reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-485983